← Leaderboards
Albee Messing
University Of Wisconsin Madison
$10,958,925
Attributed
$10,958,925
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$32,379,520 · 17
By mechanism
P01$21,861,777 · 7
P30$4,534,748 · 4
R01$2,808,057 · 2
U54$2,331,148 · 2
G20$700,000 · 1
R03$143,790 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Leonard J Abbeduto$25,006,922
- Marsha Mailick Seltzer$49,322,087
- John P Svaren$13,030,440
- Robert M. Hauser$36,785,553
- Shing Yan Chiu$8,110,486
Others in their field
Top investigators on “Glial Fibrillary Acidic Protein”
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$40,471,766
- Bharat Thyagarajan · University Of Minnesota$31,762,911
- Lee-Way Jin · University Of California At Davis$15,378,294
- Jose A Luchsinger · Columbia University Health Sciences$14,476,596
- Rachel A Whitmer · Kaiser Foundation Research Institute$14,013,722
- Paola Gilsanz · Kaiser Foundation Research Institute$14,013,722
Research focus
Glial Fibrillary Acidic ProteinAstrocytesMutantAlexander DiseaseProgramsMutationLeukodystrophyGenesIntermediate FilamentsGeneticMouse ModelPathway InteractionsBehavioralBiochemicalPhenotypeLaboratoriesTransgenic OrganismsMeetingsProteinsAnimal ModelMemberResearch PersonnelPathogenesisFiber
Grant awards (65)
Core A - Administrative Core$243,116
U54 · FY2020 · HD · contact PI
Core A - Administrative Core$242,317
U54 · FY2019 · HD · contact PI
Alexander disease: mechanisms, modifiers, and therapeutics$1,173,846
P01 · FY2018 · HD · contact PI
Genetic Modifiers and the AxD Phenotype in Mice$409,758
P01 · FY2018 · HD · contact PI
Core A - Administrative Core$242,307
U54 · FY2018 · HD · contact PI
Alexander disease: mechanisms, modifiers, and therapeutics$1,188,634
P01 · FY2017 · HD · contact PI
Genetic Modifiers and the AxD Phenotype in Mice$356,663
P01 · FY2017 · HD · contact PI
Core A - Administrative Core$244,330
U54 · FY2017 · HD · contact PI
Administrative Core$159,288
P01 · FY2017 · HD · contact PI
Alexander disease: mechanisms, modifiers, and therapeutics$1,183,404
P01 · FY2016 · HD · contact PI
Waisman Intellectual and Developmental Disabilities Research Center$1,101,600
U54 · FY2016 · HD · contact PI
Genetic Modifiers and the AxD Phenotype in Mice$312,029
P01 · FY2016 · HD · contact PI
Core A - Administrative Core$257,478
U54 · FY2016 · HD · contact PI
Administrative Core$180,882
P01 · FY2016 · HD · contact PI
Waisman Intellectual and Developmental Disabilities Research Center$1,652,183
P30 · FY2015 · HD · contact PI
Alexander disease: mechanisms, modifiers, and therapeutics$1,158,349
P01 · FY2015 · HD · contact PI
Genetic Modifiers and the AxD Phenotype in Mice$203,562
P01 · FY2015 · HD · contact PI
Administrative Core$76,460
P01 · FY2015 · HD · contact PI
Waisman Intellectual and Developmental Disabilities Research Center$1,574,277
P30 · FY2014 · HD · contact PI
Alexander disease: mechanisms, modifiers, and therapeutics$1,258,265
P01 · FY2014 · HD · contact PI
Genetic Modifiers and the AxD Phenotype in Mice$256,285
P01 · FY2014 · HD · contact PI
Administrative Core$74,997
P01 · FY2014 · HD · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$1,455,838
P01 · FY2012 · NS · contact PI
Mouse Models of Alexander Disease$692,947
P01 · FY2012 · NS · contact PI
Administrative Core$83,186
P01 · FY2012 · NS · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$1,447,328
P01 · FY2011 · NS · contact PI
Mouse Models of Alexander Disease$695,885
P01 · FY2011 · NS · contact PI
Mouse Models of Alexander Disease$367,498
R01 · FY2011 · NS · contact PI
Rodent Models Core (RMC)$326,438
P30 · FY2011 · HD · contact PI
Administrative Core$86,165
P01 · FY2011 · NS · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$1,087,568
P01 · FY2010 · NS · contact PI
Mouse Models of Alexander Disease$523,313
P01 · FY2010 · NS · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$379,250
P01 · FY2010 · NS · contact PI
Mouse Models of Alexander Disease$367,688
R01 · FY2010 · NS · contact PI
RODENT MODELS CORE$328,929
P30 · FY2010 · HD · contact PI
Administrative Core$64,704
P01 · FY2010 · NS · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$1,138,648
P01 · FY2009 · NS · contact PI
Mouse Models of Alexander Disease$360,777
R01 · FY2009 · NS · contact PI
RODENT MODELS CORE$332,251
P30 · FY2009 · HD · contact PI
Mouse Models of Alexander Disease$263,965
P01 · FY2009 · NS · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$88,917
P01 · FY2009 · NS · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$38,907
P01 · FY2009 · NS · contact PI
Administrative Core$32,527
P01 · FY2009 · NS · contact PI
Alexander Disease: Cellular and Molecular Mechanisms$1,156,001
P01 · FY2008 · NS · contact PI
Mouse Models of Alexander Disease$350,459
R01 · FY2008 · NS · contact PI
Mouse Models of Alexander Disease$264,662
P01 · FY2008 · NS · contact PI
Mouse Models of Alexander Disease$72,053
R01 · FY2008 · NS · contact PI
Administrative Core$31,964
P01 · FY2008 · NS · contact PI
Improving Waisman Center Animal Care Facility$700,000
G20 · FY2007 · RR · contact PI
Mouse Models of Alexander Disease$340,443
R01 · FY2007 · NS · contact PI
Alexander disease: cellular and molecular mechanisms$889,152
P01 · FY2006 · NS · contact PI
Is a therapy for Alexander disease already FDA-approved?$71,040
R03 · FY2006 · HD · contact PI
Alexander disease: cellular and molecular mechanisms$885,863
P01 · FY2005 · NS
Is a therapy for Alexander disease already FDA-approved?$72,750
R03 · FY2005 · HD
Alexander disease: cellular and molecular mechanisms$860,479
P01 · FY2004 · NS
Alexander disease: cellular and molecular mechanisms$836,023
P01 · FY2003 · NS
Alexander disease: cellular and molecular mechanisms$10,000
P01 · FY2003 · NS
Alexander disease: cellular and molecular mechanisms$856,063
P01 · FY2002 · NS
FUNCTION OF GFAP IN ASTROCYTE DEVELOPMENT AND DISEASE$308,615
R01 · FY2002 · NS
CORE--PATHOLOGY, HISTOLOGY AND STEREOLOGY$160,335
P30 · FY2002 · HD
Mouse models of Alexander Disease$0
P01 · FY2002 · NS
FUNCTION OF GFAP IN ASTROCYTE DEVELOPMENT AND DISEASE$299,625
R01 · FY2001 · NS
CORE--PATHOLOGY, HISTOLOGY AND STEREOLOGY$160,335
P30 · FY2001 · HD
FUNCTION OF GFAP IN ASTROCYTE DEVELOPMENT AND DISEASE$290,899
R01 · FY2000 · NS
FUNCTION OF GFAP IN ASTROCYTE DEVELOPMENT AND DISEASE$50,000
R01 · FY2000 · NS